Even if there are a few exceptions where individuals with mutations in the same gene may exhibit varied symptom progression or even different diseases (e.g., SPG4, SPG9), identifying mutated genes in HSP patients is crucial because these mutations strongly influence the pathology. The gene discussed is ALDH18A1; the disease is hereditary spastic paraplegia.